NUVB Stock Analysis: Buy, Sell, or Hold?
NUVB - Nuvation Bio Inc.
$5.97
0.20 (3.38%)
▲
5d:
+5.2%
30d:
+25.32%
90d:
+26.91%
BUY
MODERATE Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 06, 2026
22d
Smart Money Accumulation
None View Scanner →
Strength: 8.2/10
Get Alerted When NUVB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called NUVB this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: NUVB shows positive signals but monitor for confirmation. Market pricing in 0% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: NUVB shows positive signals but monitor for confirmation. Market pricing in 0% annual growth which appears achievable. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: NUVB is currently trading at $5.96, which is considered extended relative to its 30-day fair value range of $5.03 to $5.97. From a valuation perspective, the stock is trading at a discount (Forward PE: -96.2) compared to its historical average (82.8). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, NUVB is in a strong uptrend. Immediate support is located at $5.33, while resistance sits at $6.28. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.33 (+113.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NUVB is in a strong uptrend. Immediate support is located at $5.33, while resistance sits at $6.28. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.33 (+113.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$5.03 -
$5.97
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.4%)
- BULLISH: Trading 113.7% below Wall St target ($12.33)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$5.03 -
$5.97
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$5.33
Resistance Level
$6.28
Current Trend
Strong Uptrend
Technical data as of
Jul 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-96.17
Wall Street Target
$12.33
(+113.7%)
Revenue Growth (YoY)
2598.7%
Profit Margin
-102.1%
PE vs Historical
-96.2 vs 82.8
CHEAP
Share & Embed Analysis
Last updated: July 14, 2026 1:51 PM ET
Data refreshes hourly during market hours. Next update: 2:51 PM
Data refreshes hourly during market hours. Next update: 2:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NUVB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Dongfang Liu
SELL
50000 shares
2026-04-17
Kerry Wentworth
SELL
36750 shares
2026-04-17
Kerry Wentworth
SELL
200000 shares
2026-04-06
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 51 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 55 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 62 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$111 | 60 HOLD |
Advanced NUVB Option Strategies
Professional options setups generated by AI based on today's NUVB price and gamma walls.